» Articles » PMID: 39366928

Detection of Host Cell microprotein impurities In antibody Drug Products

Overview
Journal Nat Commun
Specialty Biology
Date 2024 Oct 4
PMID 39366928
Authors
Affiliations
Soon will be listed here.
Abstract

Chinese hamster ovary (CHO) cells are used to produce almost 90% of therapeutic monoclonal antibodies (mAbs) and antibody fusion proteins (Fc-fusion). The annotation of non-canonical translation events in these cellular factories remains incomplete, limiting our ability to study CHO cell biology and detect host cell protein (HCP) impurities in the final antibody drug product. We utilised ribosome footprint profiling (Ribo-seq) to identify novel open reading frames (ORFs) including N-terminal extensions and thousands of short ORFs (sORFs) predicted to encode microproteins. Mass spectrometry-based HCP analysis of eight commercial antibody drug products (7 mAbs and 1 Fc-fusion protein) using the extended protein sequence database revealed the presence of microprotein impurities. We present evidence that microprotein abundance varies with growth phase and can be affected by the cell culture environment. In addition, our work provides a vital resource to facilitate future studies of non-canonical translation and the regulation of protein synthesis in CHO cell lines.

References
1.
Ingolia N, Ghaemmaghami S, Newman J, Weissman J . Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science. 2009; 324(5924):218-23. PMC: 2746483. DOI: 10.1126/science.1168978. View

2.
Donaldson J, Kleinjan D, Rosser S . Synthetic biology approaches for dynamic CHO cell engineering. Curr Opin Biotechnol. 2022; 78:102806. DOI: 10.1016/j.copbio.2022.102806. View

3.
Tjeldnes H, Labun K, Torres Cleuren Y, Chyzynska K, Swirski M, Valen E . ORFik: a comprehensive R toolkit for the analysis of translation. BMC Bioinformatics. 2021; 22(1):336. PMC: 8214792. DOI: 10.1186/s12859-021-04254-w. View

4.
Li X, An Y, Liao J, Xiao L, Swanson M, Martinez-Fonts K . Identification and characterization of a residual host cell protein hexosaminidase B associated with N-glycan degradation during the stability study of a therapeutic recombinant monoclonal antibody product. Biotechnol Prog. 2021; 37(3):e3128. PMC: 8365702. DOI: 10.1002/btpr.3128. View

5.
Gessulat S, Schmidt T, Zolg D, Samaras P, Schnatbaum K, Zerweck J . Prosit: proteome-wide prediction of peptide tandem mass spectra by deep learning. Nat Methods. 2019; 16(6):509-518. DOI: 10.1038/s41592-019-0426-7. View